
News|Articles|June 6, 2005
New product newswire
From GlaxoSmithKline, Research Triangle Park, N.C., (919) 483-2100, comes Boostrix (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed [Tdap]). The product is indicated as a booster vaccine to be given as a single dose to patients aged 10 to 18. This booster adds a pertussis component to the tetanus/diphtheria booster routinely administered to teens.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Students’ Professional Growth Relies on AI Integration in Pharmacy School Curricula
2
Impact of Pharmacy Closures Reaches Far Beyond Medication Access
3
Pharmacy Partner in Creating Efficiency, Profitability, and Positive Patient Outcomes
4
FDA Approves Copper Histidinate Injection to Treat Menkes Disease
5










































































































































































































